PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10114721

Of orphans and balloons.

W T McGivney
View original source ↗Export metadata ↓

Abstract

Technologies with significant implications for expenditures continue to reach the health care system. These technologies range from orphan drugs/biologicals used to treat rare diseases to balloons used to treat the common occurrence of benign prostatic hyperplasia (BPH) in aging men. Because payment for these technologies can represent a serious financial drain on third-party payers, utilization has to be carefully evaluated, monitored, and controlled.

Explore related subjects

CatheterizationCost-Benefit AnalysisHumansInsurance, Health, ReimbursementMaleOrphan Drug ProductionTechnology Assessment, BiomedicalUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W T McGivney. Of orphans and balloons.. https://pubmed.ncbi.nlm.nih.gov/10114721/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes.

Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.

Catheterization↗